| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC4346 | Qs Inhibitor 1 | Novel potent inhibitor of quorum sensing (QS) pathways, strongly blocking agr-type QS in S. aureus |
|
| DCC4347 | Qs Inhibitor 2 | Novel potent inhibitor of quorum sensing (QS) pathways, strongly blocking agr-type QS in S. aureus |
|
| DCC4348 | Qtc-4-meobne | Novel multitarget anti-AD agent, significantly increasing in adult neurogenesis and remyelination through Prox1/NeuroD1 and Wnt/β-catenin pathways, demonstrating beneficial effects in preclinical models of AD |
|
| DCC4349 | Quatcy-i2 | Novel photodynamic antitumor agent |
|
| DCC4350 | Quazepam | Modulator of specific GABAA receptors via the benzodiazepine site on the GABAA receptor |
|
| DCC4351 | Quilseconazole Besylate | Potent, orally active fungal Cyp51 (lanosterol 14-α-demethylase) inhibitor |
|
| DCC4352 | Quinine Sulfate | Natural disrupter of DNA replication and transcription via DNA intercalation, reducing oxygen intake and carbohydrate metabolism and the excitability of muscle fibers, inhibiting the drug efflux pump P-glycoprotein |
|
| DCC4353 | Quoromycin | Novel antivirulence agent against Vibrio vulnificus, inhibiting the quorum-sensing signaling pathway by controlling the DNA-binding affinity of SmcR and thus effectively alleviating the virulence of V. vulnificus in vitro and in vivo |
|
| DCC4354 | Qw-296 | Novel microtubule destabilizer |
|
| DCC4355 | R-(+)-eu-1180-453 | Second-Generation GluN2C- and GluN2D-selective positive allosteric modulator (PAM) of the N-methyl-d-aspartate (NMDA) receptor |
|
| DCC4356 | R(ccug) Ligand 63 | Novel Potent and Specific Ligand of r(CCUG)exp, Targeting r(CCUG) Repeats in Myotonic Dystrophy Type 2, Facilitating Degradation by RNA Quality Control Pathways |
|
| DCC4357 | r-138329 | Novel scavenger receptor class B type I blocker |
|
| DCC4358 | r-154716 | Novel inhibitor of HDL uptake induced by overexpression of scavenger receptor BI (SR-BI) |
|
| DCC4359 | R523062 | Novel Antiviral agent for Enterovirus D68 |
|
| DCC4360 | r78206 | Efficient stabilizer of Mahoney procapsids |
|
| DCC4361 | R93274 | Potent and selective antagonist of 5-HT2A receptors |
|
| DCC4362 | Rac-azd8186 | Novel inhibitor of PI3Kβ and PI3Kδ, inhibiting growth of PTEN deficient breast and prostate tumor |
|
| DCC4363 | Racemetirosine Methyl Ester Hcl | Prodrug of Racemetirosine, an inhibitor of tyrosine 3-monooxygenase |
|
| DCC4364 | Rachelmycin | Novel potent DNA-alkylating agent, inhibiting TBP/DNA interaction |
|
| DCC4365 | Rac-nbi-74330 Featured | rac-NBI-74330 is a potent and selective CXCR3 antagonist. |
|
| DCC4366 | Rac-tofacitinib | Inhibitor of Janus kinases |
|
| DCC4367 | Rad35010 | Novel potent selective androgen receptor modulator (SARM) |
|
| DCC4368 | Radical Scavenger C7 | Potent anti-free radical agent, elevating glutathione peroxidase (GSH-PX) and super oxide dismutase (SOD) levels and lowering malonaldehyde (MDA) level in vivo in the Alzheimer's model |
|
| DCC4369 | Radicicol | Hsp90 N-terminal inhibitor |
|
| DCC4370 | Radotinib Dihydrochloride | Novel inhibitor of the tyrosine kinase BCR-ABL and platelet-derived growth factor receptor, inhibiting mitosis entry in acute myeloid leukemia cells via suppression of Aurora kinase A expression |
|
| DCC4371 | Ralimetinib | Novel potent inhibitor of p38 MAPK |
|
| DCC4372 | Ram2061 | Novel inhibitor of geranylgeranyl diphosphate synthase (GGDPS), showing significant reduction in tumor growth in mice |
|
| DCC4373 | Ram2093 | Novel inhibitor of geranylgeranyl diphosphate synthase (GGDPS) |
|
| DCC4374 | Raseglurant | Novel metabotropic glutamate type 5 (mGlu5) receptor negative allosteric modulator (NAM) |
|
| DCC4375 | R-bc154 | Potent fluorescent α4β1/α9β1 inhibitor |
|
